Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ: DMII · Real-Time Price · USD
9.97
+0.01 (0.10%)
At close: Sep 29, 2025, 4:00 PM EDT
9.98
+0.01 (0.10%)
After-hours: Sep 29, 2025, 4:00 PM EDT
Company Description
Drugs Made In America Acquisition II Corp. engages in effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Drugs Made In America Acquisition II Corp.
Country | United States |
Founded | 2024 |
IPO Date | Sep 25, 2025 |
Industry | Shell Companies |
Sector | Financials |
CEO | Lynn Stockwell |
Contact Details
Address: 1 East Broward Boulevard, Suite 700 Fort Lauderdale, Florida 33301 United States | |
Phone | 954 870 3099 |
Stock Details
Ticker Symbol | DMII |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0002040475 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Lynn Stockwell | Chief Executive Officer and Executive Chair of the Board |
Glenn Worman | Chief Financial Officer |
Catherine Do | Director Nominee |
G. Sridhar Prasad | Director Nominee |
Myron W. Shulgan | Director Nominee |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 25, 2025 | 424B4 | Prospectus |
Sep 24, 2025 | EFFECT | Notice of Effectiveness |
Sep 24, 2025 | CERT | Certification by an exchange approving securities for listing |
Sep 24, 2025 | 8-A12B | Registration of securities |
Sep 16, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Sep 15, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Sep 5, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jul 21, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Apr 25, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Mar 19, 2025 | DRS | [Cover] Draft Registration Statement |